Kleiner Perkins Caufield & Byers was tied for the most active U.S. VC in the first quarter, according to peHUB’s analysis of data from Thomson Reuters (publisher of this blog). Overall, the storied Sand Hill Road firm backed 30 companies, up from 19 in the same period a year earlier, but down slightly from 35 [...]
You are browsing the archive for CardioDx - peHUB.
CardioDx, a Palo Alto, Calif.-based provider of cardiovascular genomic diagnostics, has raised $5 million in Series D funding from the GE Healthymagination Fund. The investment is part of a larger round, which a regulatory filing suggests could be worth upwards of $45.5 million ($34.5m sold so far). Other shareholders include Kleiner Perkins Caufield & Byers, TPG Biotech, Intel Capital, MDV, DAG Ventures, Pappas Ventures and Asset Management Group.